1Carapetis JR,Steer AC,Mulholland EK,et al.The global burden of group A streptococcal diseases.Lancet Infect Dis,2005,5:685-694.
2Krause RM.Evolving microbes and re-emerging streptococcal disease.J Clin Lab Med,2002,22:835-848.
3Chiou CS,Liao TL,Wang TH,et al.Epidemiology and molecular characterization of streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999.J Clin Microbiol,2004,42:3998-4006.
4Perea-Mejia LM,Inzunza-Montiel AE,Cravioto A.Molecular characterization of group A streptococcus strains isolated during a scarlet fever outbreak.J Clin Microbiol,2002,40:278-280.
5Descheemaeker P,Van Loock F,Hauchecome M,et al.Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994.J Med Microbiol,2000,49:467-471.
6Green NM,Beres SB,Graviss EA,et al.Genetic diversity among type emm28 group A streptococcus strains causing invasive infections and pharyngitis.J Clin Microbiol,2005,43:4083-4091.
7Nandi S,Chakraborti A,Bakshi DK,et al.Association of pyrogenic exotoxin genes with pharyngitis and rheumatic fever/rheumatic heart disease among Indian isolates of streptococcus pyogenes.Lett Appl Microbiol,2002,35:237-241.
8Lindbaek M,Hoiby EA,Lermark G,et al.Which is the best method to trace group A streptococci in sore throat patients:culture or GAS antigen test? Scand J Prim Health Care,2004,22:233-238.
9Leung AK,Kellner JD.Group A beta-hemolytic streptococcal pharyngitis in children.Adv Ther,2004,21:277-287.
10Colletti T,Robinson P.Strep throat:guidelines for diagnosis and treatment.JAAPA,2005,18:38-44.
8Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement[S]. CLSI 2007 M100 - S17:59.
9Beall B, R Facklam, T Thompson. Sequencing emm - specific PCR products for routine and accurate typing of group A streptococci [ J ]. J Clin Microbiol, 1996, 34:953 - 958.
